Finfeed Archived Jun 18, 2020
PharmAust (ASX: PAA) received positive news regarding the performance of its treatments in reducing SARS-CoV-2 (COVID-19)
Get expert stock analysis direct in your inbox
Join OurMailing List
Discover Small CapBiotech Stocks
Join thousands of other Investors following our stock commentary for Free
